Bitter melon extract clinical trials
How each study uses bitter melon extract is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the bitter melon extract studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
Universitas Muhammadiyah Surakarta (2) · Midwest Center for Metabolic and Cardiovascular Research (1) · Syamsudin Abdillah,Ph.D, Pharm D (1)
Often tested with
Tested in the same studies.
Giant snakehead (2) · Momordica charantia (1) · Artenimol (1) · Piperaquine (1) · Primaquine (1)
Studies
Open first, then newest update. How each study uses bitter melon extract is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Combined Bitter Melon Extract and Snakehead Fish Powder Supplementation for Glycemic Control in Type 2 DiabetesNot yet recruitingNot applicableUniversitas Muhammadiyah SurakartaNCT07302178Written as Snakehead Fish Powder + Bitter Melon Extract
- Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes MellitusCompletedNot applicableUniversitas Muhammadiyah SurakartaNCT07303127Written as Bitter Melon Extract and Snakehead Fish Powder Combination
- Effects of Bitter Melon on Cardiometabolic HealthCompletedNot applicableMidwest Center for Metabolic and Cardiovascular ResearchNCT05540405Written as Low-dose bitter melon
- Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba RegencyCompletedPhase 2Syamsudin Abdillah,Ph.D, Pharm DNCT05829187Written as Momordica Charantia Extract
Codes
What other systems call bitter melon extract · ClinicalTrials.gg INT001547
- MeSH (NLM) C000713349bitter melon extractOne source NLM
- RxNorm 1306885One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000713349 | bitter melon extract | One source NLM |
| RxNorm | 1306885 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.